Piśmiennictwo:

1. Strand MS, Lockhart AC, Fields RC. Genetics of Gastric Cancer. Surg Clin North Am 2017;97(2):345-370.

2. Choi YY, Noh SH, Cheong JH. Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine. Yonsei Med J 2015;56(5):1177-85.

3. Cristescu R, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med 2015;21(5):449-56.

4. Chen T, Xu XY, Zhou PH. Emerging molecular classifications and therapeutic implications for gastric cancer. Chin J Cance 2016;35:49.

5. Yan L. The journey of personalizing gastric cancer treatment. Chin J Cancer 2016;35(1):84.

6. Polom K, Marrelli D, Pascale V, et al. The pattern of lymph node metastases in microsatellite unstable gastric cancer. Eur J Surg Oncol 2017;43(12):2341-2348.

7. Polom K, Das K, Marrelli D, et al. KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status. Pathol Oncol Res 2017. Dostęp: 10.1007/s12253-017-0348-6. [Epub ahead of print]

8. Polom K, Marrelli D, Roviello G, et al. Molecular key to understand the gastric cancer biology in elderly patients-The role of microsatellite instability. J Surg Oncol 2017;115(3):344-350.